<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yende S</submitter><funding>NIGMS NIH HHS</funding><pagination>1242-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2720087</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>177(11)</volume><pubmed_abstract>&lt;h4>Rationale&lt;/h4>Survivors of hospitalization for community-acquired pneumonia (CAP) are at increased risk of cardiovascular events, repeat infections, and death in the following months but the cause is unknown.&lt;h4>Objectives&lt;/h4>To investigate whether persistent inflammation, defined as elevating circulating inflammatory markers at hospital discharge, is associated with subsequent outcomes.&lt;h4>Methods&lt;/h4>Prospective cohort study at 28 sites.&lt;h4>Measurements and main results&lt;/h4>We used standard criteria to define CAP and the National Death Index to determine all-cause and cause-specific 1-year mortality. At hospital discharge, 1,799 subjects (77.5%) were alive and vital signs had returned to normal in 1,512 (87%) subjects. The geometric means (+/-SD) for circulating IL-6 and IL-10 conce</pubmed_abstract><journal>American journal of respiratory and critical care medicine</journal><pubmed_title>Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.</pubmed_title><pmcid>PMC2720087</pmcid><funding_grant_id>R01 GM61992</funding_grant_id><pubmed_authors>Welch RD</pubmed_authors><pubmed_authors>Knestaut L</pubmed_authors><pubmed_authors>Clark M</pubmed_authors><pubmed_authors>Siegel M</pubmed_authors><pubmed_authors>Weinberg J</pubmed_authors><pubmed_authors>Degutis LC</pubmed_authors><pubmed_authors>Solot J</pubmed_authors><pubmed_authors>Campbell TP</pubmed_authors><pubmed_authors>Shah K</pubmed_authors><pubmed_authors>Waddell L</pubmed_authors><pubmed_authors>Finegold D</pubmed_authors><pubmed_authors>Waselewsky D</pubmed_authors><pubmed_authors>Becich M</pubmed_authors><pubmed_authors>Fine JM</pubmed_authors><pubmed_authors>Holland S</pubmed_authors><pubmed_authors>Riordan R</pubmed_authors><pubmed_authors>Yuan X</pubmed_authors><pubmed_authors>Woods H</pubmed_authors><pubmed_authors>Morrow D</pubmed_authors><pubmed_authors>Pappu S</pubmed_authors><pubmed_authors>Nicholas J</pubmed_authors><pubmed_authors>Rosenbloom J</pubmed_authors><pubmed_authors>Pagano A</pubmed_authors><pubmed_authors>Wunderink RG</pubmed_authors><pubmed_authors>Christie J</pubmed_authors><pubmed_authors>Welch R</pubmed_authors><pubmed_authors>Heath R</pubmed_authors><pubmed_authors>He S</pubmed_authors><pubmed_authors>Fiehler PC</pubmed_authors><pubmed_authors>D'Angelo G</pubmed_authors><pubmed_authors>Martino M</pubmed_authors><pubmed_authors>Hewlett C</pubmed_authors><pubmed_authors>Jacobs B</pubmed_authors><pubmed_authors>Mostoufi M</pubmed_authors><pubmed_authors>Murcek MA</pubmed_authors><pubmed_authors>Saka G</pubmed_authors><pubmed_authors>Guzik LJ</pubmed_authors><pubmed_authors>Angus DC</pubmed_authors><pubmed_authors>Kessler L</pubmed_authors><pubmed_authors>Bucala R</pubmed_authors><pubmed_authors>Delbridge T</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Roberts MS</pubmed_authors><pubmed_authors>Weissfeld LA</pubmed_authors><pubmed_authors>Buono D</pubmed_authors><pubmed_authors>Riley P</pubmed_authors><pubmed_authors>Geyer S</pubmed_authors><pubmed_authors>Casey S</pubmed_authors><pubmed_authors>Weissfeld L</pubmed_authors><pubmed_authors>Gaudio F</pubmed_authors><pubmed_authors>Tang X</pubmed_authors><pubmed_authors>Rocker E</pubmed_authors><pubmed_authors>Kong L</pubmed_authors><pubmed_authors>Bernstein LH</pubmed_authors><pubmed_authors>Kruse J</pubmed_authors><pubmed_authors>St Clair C</pubmed_authors><pubmed_authors>Reynholds B</pubmed_authors><pubmed_authors>Auble TE</pubmed_authors><pubmed_authors>Nunnink K</pubmed_authors><pubmed_authors>Greenhouse D</pubmed_authors><pubmed_authors>Ergas S</pubmed_authors><pubmed_authors>Greer K</pubmed_authors><pubmed_authors>Patti M</pubmed_authors><pubmed_authors>Kellum JA</pubmed_authors><pubmed_authors>Joyce C</pubmed_authors><pubmed_authors>GenIMS Investigators</pubmed_authors><pubmed_authors>Basheda S</pubmed_authors><pubmed_authors>Sterling H</pubmed_authors><pubmed_authors>Papa R</pubmed_authors><pubmed_authors>Schaefer A</pubmed_authors><pubmed_authors>Wood KA</pubmed_authors><pubmed_authors>Hebda S</pubmed_authors><pubmed_authors>Moldovan J</pubmed_authors><pubmed_authors>Kreke J</pubmed_authors><pubmed_authors>Fink MP</pubmed_authors><pubmed_authors>Olson N</pubmed_authors><pubmed_authors>Laman D</pubmed_authors><pubmed_authors>Scinto L</pubmed_authors><pubmed_authors>Powell TA</pubmed_authors><pubmed_authors>Betcher K</pubmed_authors><pubmed_authors>Haddad R</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Yee E</pubmed_authors><pubmed_authors>Grogan A</pubmed_authors><pubmed_authors>Scherzer H</pubmed_authors><pubmed_authors>Bowman MV</pubmed_authors><pubmed_authors>Greenwald K</pubmed_authors><pubmed_authors>Strimlan CV</pubmed_authors><pubmed_authors>Singh J</pubmed_authors><pubmed_authors>Werdmann M</pubmed_authors><pubmed_authors>Darnley A</pubmed_authors><pubmed_authors>Dunne R</pubmed_authors><pubmed_authors>Yende S</pubmed_authors><pubmed_authors>Wells A</pubmed_authors><pubmed_authors>Arena V</pubmed_authors><pubmed_authors>Maggi G</pubmed_authors><pubmed_authors>Carter M</pubmed_authors><pubmed_authors>Young TL</pubmed_authors><pubmed_authors>Probst R</pubmed_authors><pubmed_authors>Cooper GF</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Flynn E</pubmed_authors><pubmed_authors>Feingold E</pubmed_authors><pubmed_authors>Tracey KJ</pubmed_authors><pubmed_authors>Null T</pubmed_authors><pubmed_authors>Graff LM</pubmed_authors><pubmed_authors>Wunderink R</pubmed_authors><pubmed_authors>Yealy DM</pubmed_authors><pubmed_authors>Hoteck T</pubmed_authors><pubmed_authors>Dooley C</pubmed_authors><pubmed_authors>Carius M</pubmed_authors><pubmed_authors>Martinez J</pubmed_authors><pubmed_authors>Krifcher C</pubmed_authors><pubmed_authors>Mandich LA</pubmed_authors><pubmed_authors>Gigler J</pubmed_authors><pubmed_authors>Friedman L</pubmed_authors><pubmed_authors>Bilicki K</pubmed_authors><pubmed_authors>Pinsky MR</pubmed_authors><pubmed_authors>McCaw M</pubmed_authors><pubmed_authors>Walshon J</pubmed_authors><pubmed_authors>Krichevsky A</pubmed_authors><pubmed_authors>McNamme M</pubmed_authors><pubmed_authors>Borochovitz D</pubmed_authors><pubmed_authors>Grant R</pubmed_authors><pubmed_authors>Rivers E</pubmed_authors><pubmed_authors>Morris A</pubmed_authors><pubmed_authors>Ferrell R</pubmed_authors><pubmed_authors>Kristan W</pubmed_authors><pubmed_authors>Jatlow P</pubmed_authors><pubmed_authors>Nair S</pubmed_authors><pubmed_authors>Chaudhry R</pubmed_authors><pubmed_authors>Castor E</pubmed_authors><pubmed_authors>Hufnagel M</pubmed_authors><pubmed_authors>MacLeod B</pubmed_authors><pubmed_authors>Rolniak S</pubmed_authors><pubmed_authors>Shaufl A</pubmed_authors><pubmed_authors>Wolf S</pubmed_authors><pubmed_authors>Hewitt L</pubmed_authors><pubmed_authors>Gorsha N</pubmed_authors><pubmed_authors>Visweswaran S</pubmed_authors><pubmed_authors>Rahim M</pubmed_authors><pubmed_authors>Khasnabis S</pubmed_authors><pubmed_authors>Fine J</pubmed_authors><pubmed_authors>Kuzma J</pubmed_authors><pubmed_authors>Campbell L</pubmed_authors><pubmed_authors>Anderson J</pubmed_authors><pubmed_authors>Naples M</pubmed_authors><pubmed_authors>Bennett N</pubmed_authors><pubmed_authors>Delude RL</pubmed_authors><pubmed_authors>Belden C</pubmed_authors><pubmed_authors>Furman A</pubmed_authors><pubmed_authors>Kumar RK</pubmed_authors><pubmed_authors>Provenzano M</pubmed_authors><pubmed_authors>Fine MJ</pubmed_authors><pubmed_authors>DeLuca C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.</name><description>&lt;h4>Rationale&lt;/h4>Survivors of hospitalization for community-acquired pneumonia (CAP) are at increased risk of cardiovascular events, repeat infections, and death in the following months but the cause is unknown.&lt;h4>Objectives&lt;/h4>To investigate whether persistent inflammation, defined as elevating circulating inflammatory markers at hospital discharge, is associated with subsequent outcomes.&lt;h4>Methods&lt;/h4>Prospective cohort study at 28 sites.&lt;h4>Measurements and main results&lt;/h4>We used standard criteria to define CAP and the National Death Index to determine all-cause and cause-specific 1-year mortality. At hospital discharge, 1,799 subjects (77.5%) were alive and vital signs had returned to normal in 1,512 (87%) subjects. The geometric means (+/-SD) for circulating IL-6 and IL-10 conce</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Jun</publication><modification>2025-04-22T21:51:33.092Z</modification><creation>2019-03-27T00:23:57Z</creation></dates><accession>S-EPMC2720087</accession><cross_references><pubmed>18369199</pubmed><doi>10.1164/rccm.200712-1777OC</doi><doi>10.1164/rccm.200712-1777oc</doi></cross_references></HashMap>